Search

International audience; Allergic asthma is characterized by elevated levels of IgE antibodies, type 2 cytokines such as interleukin-4 (IL-4) and IL-13, airway hyperresponsiveness (AHR), mucus hypersecretion and eosinophilia. Approved therapeutic monoclonal antibodies targeting IgE or IL-4/IL-13 reduce asthma symptoms but require costly lifelong administrations. Here, we develop conjugate vaccines against mouse IL-4 and IL-13, and demonstrate their prophylactic and therapeutic efficacy in reducing IgE levels, AHR, eosinophilia and mucus production in mouse models of asthma analyzed up to 15 weeks after initial vaccination. More importantly, we also test similar vaccines specific for human IL-4/IL-13 in mice expressing human IL-4/IL-13 and the related receptor, IL-4Rα, to find efficient neutralization of both cytokines and reduced IgE levels for at least 11 weeks post-vaccination. Our results imply that dual IL-4/IL-13 vaccination may represent a cost-effective, long-term therapeutic strategy for the treatment of allergic asthma as demonstrated in mouse models, although additional studies are warranted to assess its safety and feasibility.

Metal Organic Frameworks, MOFs, are porous crystalline solid based on metal clusters and organic ligands, investigated for numerous applications such as catalysis, drug delivery, gas storage and, more recently, biosensors. The work presented in this thesis focuses on functionalizing MOFs through different strategies, such as covalent grafting or surface coordination chemistry, through chemical reactions, such as peptide coupling or synthesis of urea. In particular, a new method to very quickly graft chiral peptides into the nanopores of MOFs is reported. A large library of MOF-peptides has thus been obtained and characterized. These novel compounds have also been used for grafting organometallics in the cavities of MOFs. Following a post-synthetic ligand exchange, it was also possible to integrate a photocatalytic complex in the structure of a MOF, improving its activities and selectivities for the photocatalytic CO2 reduction. In general, the catalytic performances of these materials were superior to those of their homogeneous counterparts, thus further expanding the potential of MOFs as well-defined heterogeneous catalysts for fine chemistry, Les MOFs sont des solides à la structure cristalline poreuse à base de clusters métalliques et de ligands organiques qui font l'objet de très nombreuses études, dans des champs d'applications très variés, qui vont de la catalyse au « drug delivery », en passant par le stockage de gaz et, plus récemment, en tant que senseurs biologiques. Les ligands organiques, qui les constituent, peuvent lorsqu'ils possèdent un point d'ancrage, comme des groupements amino, être fonctionnalisés grâce à des réactions chimiques. Les travaux présentés dans cette thèse reportent la fonctionnalisation de MOFs, via différentes stratégies, comme des greffages covalent et issues de la chimie de coordination, tel que le couplage peptidique ou encore la synthèse d'urée. Dans cette thèse, est notamment présentée une nouvelle méthode permettant de greffer très rapidement des peptides chiraux dans les nanopores des MOFs. Une large bibliothèque MOF-peptides a ainsi été obtenue et caractérisée. Ces nouveaux composés ont également été utilisés pour l'ancrage de complexes organométalliques dans les cavités des MOFs. Suivant un échange de ligands post-synthétique, il a aussi été possible d'intégrer un complexe organométallique photo-catalytique dans la structure d'un MOF, améliorant ainsi ses activités et sélectivités pour la photo-réduction de CO2. Enfin, les performances catalytiques de ces derniers matériaux MOFs se sont révélées supérieures aux versions homogènes des complexes, ce qui offre de nouvelles opportunités pour la catalyse fine

International audience; The propagation of yeast prion phenotypes is highly dependent on molecular chaperones. We previously demonstrated that the molecular chaperone Ssa1p sequesters Ure2p in high molecular weight, assembly incompetent oligomeric species. We also determined the affinity of Ssa1p for Ure2p, and its globular domain. To map the Ure2p-Ssa1p interface, we have used chemical cross-linkers and MS. We demonstrate that Ure2p and Ssa1p form a 1 : 1 complex. An analytical strategy combining in-gel digestion of cross-linked protein complexes, and both MS and MS/MS analysis of proteolytic peptides, allowed us to identify a number of peptides that were modified because they are exposed to the solvent. A difference in the exposure to the solvent of a single lysine residue, lysine 339 of Ure2p, was detected upon Ure2p-Ssa1p complex formation. These observations strongly suggest that lysine 339 and its flanking amino acid stretches are involved in the interaction between Ure2p and Ssa1p. They also reveal that the Ure2p amino-acid stretch spanning residues 327-339 plays a central role in the assembly into fibrils.